Speculation
The onset of response to different mitogens (PHA, PWM, and Con A) apparently fails to distinguish subpopulations of lymphocytes in most fetal organs tested. Such agents may be of restricted value in studies of early immune ontogeny. Observation of one case of apparent fetal sensitization to SLO at 19 weeks gestational age suggests that transplacental immunization without gross infection may not be as rare as is believed currently.
In addition, we were intrigued by the findings that a small number of samples of new born cord blood were stimulated to divide in vitro by various ubiquitous antigens such as streptolysin 0 and pneumococcus type 1 (14, 21) . Since these in vitro lymphocyte proliferative responses to specific antigens were believed to show prior sensitization, it seemed important to find out whether such responses could be detected earlier in fetal life.
Using a whole blood lymphocyte transformation technique (3) similar to that of Pauly et al. (18) , we examined the responses of blood and tissues to the mitogens PHA, PWM, and Con A , as well as to certain specific antigens, in 30 fetuses ranging in gestational age from 6-19 weeks. To our knowledge this is the first report of studies in an ontogenetic survey of human fetal lyrnphocytes stimulated with Con A and specific antigens.
MATERIALS AND METHODS

PREPARATION OF LYMPHOID CELL SUSPENSIONS
Thirty nonviable human fetuses were obtained from therapeutic hysterectomy specimens submitted to pathology from patients giving informed consent. The fetuses were between 6 and 19 weeks of gestational age as determined by crown-rump length using the data of Moore (15) . Thymus, spleen, and liver were rapidly dissected and placed in petri dishes containing Earle's minimal essential medhm (MEM) supplemented with 20% fetal Only in the last decade has it been generally recognized that calf serum, 200 pg streptomycinlml, and 100 pg erythromycin/ the human fetus develops an immunologic potential at a very ml. Tissues were carefully minced and pressed through stainless stage of growth. In the ontogenetic of immune steel 100 mesh screens. Bone marrow was obtained by flushing response; a variety of in vitro assays have been used. For cell-bones with medium containing 40 U/ml sodium heparin Illediated the transformation responses of lymph'-(Fisher). Blood was drawn from the umbilical cord and placed 'ytes and PWM have been by various in approximately 2 ml heparinized medium. All cell suspensions map the lymph-were counted and adjusted to 5 x 105 viable mononuclear cells/ oid cells, Mitogen responsiveness has been found in thymocytes ml medium. as early as 10-12 weeks of gestation, and positive responses have been detected in blood and splenic lymphocytes about 2-4 weeks later (2, 5, 13, 16, 17, 19) .
It is now well established that a marked heterogeneity exists among lymphoid cells in terms of ontogeny, function, and cell surface differentiation markers. Recently, it has been found that the relative reactivities to mitogens PHA, PWM, and Con A may serve as a useful probe for distinguishing bone marrowdependent lymphocytes (B cells) and thymus-dependent lymphocytes (T cells) (1, 7, 11, 12) as well as subsets of T lymphocytes (20) . Therefore, it appeared to us that an ontogenetic study of the relative reactivities in the lymphoid tissues of fetuses to different mitogens may reveal further information on the rates of maturation of various fetal lymphoid subpopulations.
PREPARATION OF LYMPHOID CELL CULTURES
Triplicate cultures were set up with 2 ml of the above cell suspension (lo6 cellsltube) in loosely capped, disposable, glass culture tubes (16 x 125 mm) containing either 0.1 ml phosphate buffered saline (PBS), pH 7.4, for unstimulated controls, or one of the following antigens and mitogens: ( I ) PHA the day of harvest was more crucial than dose response; there-RESULTS fore, when the number of cells permitted, triplicate cultures were set UD for dav 2-dav 7 and harvested after incubation in a IN VITRO RESPONSE TO PHA, PWM, AND CON A humidified incubator with 5 % C 0 2 in air. Most specimens a p peared to give their peak response at day 3-day 5 and these days were selected when material was limited.
Eighteen to 24 hr before harvesting, 1 pCi tritiated thymidine (specific activity = 13 Ci/mmol) was added to each tube. Cells were vortexed and incubated for the remaining period. Harvesting was accomplished by first removing the supernatant from the cell pellet. In most cases the cells were then frozen at -20" until the following day. We had previously determined that freezing at this stage had little or no effect on the final isotope counting. The cell pellet received 3 ml cold distilled water, was vortexed, and was centrifuged at 1120 X g for 10 min. This procedure was repeated a second time, after which the pellet was precipitated with 3 ml 5% cold trichloroacetic acid (TCA). After spinning at 2510 x g for 10 min, the TCA-precipitated material was resuspended in 3 ml cold methanol and again spun at 2510 x g for 10 min.
PREPARATION FOR LIQUID SCINTILLATION COUNTING
The washed pellet was dissolved in 0.2 ml 0.1 N sodium hydroxide. Ten milliliters of the liquid scintillation mixture (scintanalyzed toluene (Fisher) + 0.01% POPOP (Packard) + 0.4% butyl-PBD (Beckman) + 10% Bio-Solv BBS-3 (Beckman)) was added to each tube and poured into counting vials. An additional 2 ml of the mixture was used to rinse the tube. The vials were counted in a Beckman LS 150 after at least 2 hr of equilibration.
ANALYSIS OF DATA
Data were analyzed following the method of Stites et al. (19) .
The average count per minute (CPM) for the triplicate samples was calculated. Differences in CPM between PBS control and stimulated cultures were tested for statistical significance by Student's t-test. Any difference with P value equal or less than 0.05 was considered significant. In addition, a stimulation index (SI) was calculated by dividing the average CPM of PBS controls into the average CPM of stimulated cultures. SI values were useful in reflecting the magnitude of response in data comparison. Tables 1-3 show the responses of fetal thymus, spleen, and cord blood tissues to three mitogens (PHA, PWM, and Con A). Because there were essentially no responses in fetuses younger than 11 weeks gestational age (GA), only data obtained from fetuses 11 weeks or older are presented.
In terms of the time of onset, thymocytes (Table 1 ) responded first to PHA and PWM at about 12-13 weeks G A and to Con A at around 14 weeks. Cord blood (Table 2 ) responsiveness appeared at 13-14 weeks for all three mitogens, whereas splenocytes (Table 3) responded at 14 weeks to all three mitogens.
No significant responses were found in any of the fetal liver cell cultures from the 30 fetuses studied. Similarly, negative data were obtained with bone marrow cell cultures in all except two cases. Bone marrow cells of fetus 18b showed a low but significant response to PHA with good agreement in all three triplicate cultures (CPM = 5,004 + 366, P < 0.001; SI = 3.3).
Bone marrow cells of fetus 1 9 b also showed low but significant responses to all three mitogens (PHA: CPM = 278 + 22, P < 0.02, SI = 1.7; PWM: CPM = 728 + 92, P < 0.01, SI = 4.6;
Con A: CPM = 330 + 21, P < 0.01, SI = 2.0).
Judging from both the CPM and the SI values, the peak PHA response in thymocytes ( Table 1 ) appeared to occur very early; the highest responses were at 14 and 15 weeks, only 2 weeks after the onset of responsiveness. After this period, PHA responsiveness generally decreased to insignificant levels by 19 weeks of GA. The peak'responses to PWM and Con A in thymocytes are harder to pinpoint, but the stronger responses observed were in fetuses 14-17 weeks of GA for PWM and 14-18 weeks of G A for Con A. Thus, mitogenic responses in thymocytes appear to be age related.
In the c.ord blood (Table 2) , there were no peaks discernible in the responses to PHA, PWM, and Con A. Instead the mitogenic responses in cord blood seem to increase gradually from 13-19 weeks of GA with some fluctuations in the interim. At 13 weeks of GA, there appear to be stronger responses to PHA than to PWM or Con A; however, at 19 weeks of G A the responses are nearly the same. In the spleen (Table 3) , the CPM values of cultures stimulated by all three mitogens were highest at 1 4 weeks of G A but the corresponding background CPM in DISCUSSION control cultures were also the highest. ~n a l~s i s of the SI profiles reveals no discernible peak response for all three mitogens. Interestingly, although splenocytes responded t o all three mitogens beginning a t 1 4 weeks of G A , PWM responsiveness was consistently lower than the response to P H A and Con A , with the P H A response slightly lower than the Con A response. In contrast, this phenomenon was not observed in the mitogenic responses of either the thymocytes or the cord blood cells.
IN VITRO RESPONSE TO SPECIFIC ANTIGENS
In the present study, we have investigated the proliferative responses of various human fetal lymphoid tissues to three mitogens (PHA, PWM, and Con A ) and four antigens (SLO, KLH, SKSD, and PPD) using a whole blood lymphocyte transformation technique. Positive responsiveness to all three mitogens was observed t o occur between 1 2 and 14 weeks of G A in the thymus, 13-14 weeks in cord blood, and at 14 weeks in the spleen. Mitogen responsiveness was consistently negative in liver and in bone marrow of fetuses younger than 18 weeks of G A . Thus, our results generally confirmed the previous None of the cultures developed significant responses to KLH, reports of fetal lymphocyte responsiveness to mitogens P H A SKSD, or PPD. Positive responses to SLO were demonstrated and PWM (2, 5 , 13, 16, 17, 19) . blood and in the spleen. In the thymus, Con A.responsiveness possibly lagged 1-2 weeks behind PHA and PWM responsiveness. Therefore, we were unable to define the rates of maturation of various human fetal lymphocyte subpopulations by use of the differential mitogen reactivity as did Stobo (20) in the murine system. previ&sly, Papiernik (17) observed that the magnitude of mitogen resvonsiveness in the thvmus varied as a function of fetalYage. ifo ore 20 weeks of GA: the stimulation by PHA and PWM was higher, but after 20 weeks it was reduced to a level similar to that of the newborn infant. This change was correlated with the histologic and cytologic composition of the thymus and coincided with the appearance of mature lymphocytes in the thymic cortex. We also found that the magnitude of response of thymocytes to all three mitogens appeared to be highest between 14 and 18 weeks. After 18 weeks of GA, mitogen responsiveness in the thymus decreased. This age-related diminution of mitogen responses was not observed in either the spleen or cord blood.
Analysis of PHA to Con A or PHA to PWM ratios at various fetal ages revealed no discernible patterns in the relative responses to the three mitogens in either the thymus or the cord blood. However, in the spleen of fetuses 15-19 weeks old, the response to PWM was consistently lower than the responses to PHA and Con A. The differential response is unexplained. However, it could represent a further differentiation of T cells during the journey from thymus to spleen, different ratios of T and B cells in the spleen, or altered suppressor cell kinetics.
Although exhibited low but significant degree of mitogen responsiveness. Although our findings are inconclusive it is possible that in fetuses 18 weeks or older, a low degree of mitogen responsiveness may be demonstrated in the bone marrow. As have others (2, 4, 22) , we found that the control cultures of unstimulated fetal lymphocytes usually incorporate much more thymidine than do adult lymphocytes. Stites et al. (19) , working with Ficoll-Hypaque purified lymphocytes, found the highest spontaneous transformation to occur in the marrow and blood of human fetuses (5-19 weeks of GA); next in order were the liver, spleen, and thymus, respectively. In our whole blood culture system, we observed the highest spontaneous transformation in the spleen, and then in bone marrow, liver, cord blood, and thymus, respectively. Interpretation of the significance of a positive stimulation by SI values would bias results when low control cultures are compared to those with high spontaneous control cultures; therefore, we used the Student's ttest to assess the significance of responses.
The in vitro specific antigen responses were interesting. Although none of the lymphoid cultures developed significant transformations to KLH, SKSD, or PPD, one fetus, 196, had significant responses to SLO demonstrable both in the bone marrow and in the cord blood. The response in cord blood occurred only on one day (day 3, CPM = 11,444 + 1,776 P < 0.02, SI = 7.3), but the response in bone marrow was confirmed by significant responses on day 3 (CPM = 429 + 36, P < 0.05, SI = 26), day 5 (CPM = 3,410 2 250, P < 0.001, SI = 13.5) and day 7 (CPM = 584 2 66, P < 0.01, SI = 3.7). Interestingly, this fetus' bone marrow also demonstrated positive response to all three mitogens. As far as we know, this is the first report of human fetal blood and bone marrow cells responding to a specific antigen in the lymphocyte transformation assay. No gross pathologic evidence of infection was found in fetus 196. If our finding of SLO reactivity represents true prenatal sensitization (and not a spurious or primary in vitro response), de novo sensitization by transplacental passage of the antigen without gross infection may occur more often than we realize. Of course such a response might be due to transplacental maternal cells or to a "transfer factor-like" phenomenon (9) from the mother. Unfortunately, concomitant studies on the mother were not done. We feel that the argument against a spurious or nonimmune cell response is strengthened (I) by the stimulation in triplicate tubes ( 2 ) by the fact that SLO and PWM stimulation tended to be confirmed on several days' runs, and (3) by the concurrent stimulation in cord blood. Similar surveys are needed to confirm these observations and to determine the gestational age at which antigenic sensitization can first be demonstrated by lymphocyte transformation in the human fetus.
CONCLUSION
Results of a study using whole blood (tissue) lymphocyte tranformation technique in 30 human fetuses (6-19 weeks) tend to confirm earlier estimates of the time of onset of responsiveness to PHA and PWM in various fetal lymphoid materials. Our study suggests that Con A responsiveness develops in concert with that of PHA and PWM. Interestingly, one 19-week fetus had an apparent antigen specific response to streptolysin 0. This response might represent an instance of immune prenatal sensitization.
